174
Views
4
CrossRef citations to date
0
Altmetric
Original Research

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress

, , , , , , & show all
Pages 647-657 | Published online: 11 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nan Xu, Siqi Liu, Yongqiang Zhang, Yujing Chen, Yumei Zuo, Xiaoqiu Tan, Bin Liao, Pengyun Li & Jian Feng. (2023) Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin. Redox Report 28:1.
Read now

Articles from other publishers (3)

Jing-Ya Li, Chun-Chun Zhao, Jian-Fei Peng, Meng Zhang, Liang Wang, Gang Yin & Peng Zhou. (2022) The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-12.
Crossref
Chunhua Liu, Yaqian Feng, Dazheng Zhou, Aichun Ju, Junping Kou, Boyang Yu & Jin Qi. (2022) Sheng-Mai San extracts attenuate heart injury in chronic intermittent hypoxia via suppressing oxidative damage and regulating glucose metabolism. Pharmacological Research - Modern Chinese Medicine 5, pages 100194.
Crossref
Zhenchao Niu, Tingting Qiang, Wenyong Lin, Yiping Li, Keyan Wang, Dan Wang & Xiaolong Wang. (2022) Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro. Frontiers in Pharmacology 13.
Crossref